Skip to content
LongBio Pharma
-
LongBio Pharma debuts on Hong Kong Stock Exchange with US$1.37B valuation
The company officially listed on the Hong Kong Stock Exchange on June 5, achieving a market valuation of approximately HK$10.7 billion (US$1.37 billion) following its debut.